X4 Pharmaceuticals Inc (NASDAQ: XFOR) on Monday, plunged -0.84% from the previous trading day, before settling in for the closing price of $0.57. Within the past 52 weeks, XFOR’s price has moved between $0.26 and $1.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -25.00%. The company achieved an average annual earnings per share of 77.49%. With a float of $117.85 million, this company’s outstanding shares have now reached $168.51 million.
Considering the fact that the conglomerate employs 93 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 85.2%, operating margin of -618.81%, and the pretax margin is -398.61%.
X4 Pharmaceuticals Inc (XFOR) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of X4 Pharmaceuticals Inc is 30.90%, while institutional ownership is 35.60%. The most recent insider transaction that took place on Nov 15 ’24, was worth 12,583. In this transaction President and CEO of this company sold 31,897 shares at a rate of $0.39, taking the stock ownership to the 993,919 shares. Before that another transaction happened on Nov 15 ’24, when Company’s Officer proposed sale 31,897 for $0.41, making the entire transaction worth $13,078.
X4 Pharmaceuticals Inc (XFOR) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 77.49% per share during the next fiscal year.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Trading Performance Indicators
X4 Pharmaceuticals Inc (XFOR) is currently performing well based on its current performance indicators. A quick ratio of 4.80 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 86.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.09, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of X4 Pharmaceuticals Inc (XFOR)
Compared to the last year’s volume of 3.21 million, its volume of 3.79 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 9.63%. Additionally, its Average True Range was 0.10.
During the past 100 days, X4 Pharmaceuticals Inc’s (XFOR) raw stochastic average was set at 48.03%, which indicates a significant increase from 16.52% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 161.97% in the past 14 days, which was lower than the 181.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5489, while its 200-day Moving Average is $0.7734. Nevertheless, the first resistance level for the watch stands at $0.6101 in the near term. At $0.6548, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.7098. If the price goes on to break the first support level at $0.5104, it is likely to go to the next support level at $0.4554. Should the price break the second support level, the third support level stands at $0.4107.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Key Stats
Market capitalization of the company is 96.41 million based on 170,546K outstanding shares. Right now, sales total 0 K and income totals -101,170 K. The company made 560 K in profit during its latest quarter, and -36,700 K in sales during its previous quarter.
